+39 348 8125787|info@nutra-be.it

NUTRA DHA

34,90€ incl. VAT

In stock

NUTRA DHA is a dietary supplement based on DHA from oil derived from alga.

Glass bottle of 120 tablets.

1 tablet = 50mg DHA.

Recommended posology:

  • 2 tablets/day for children undergoing psycho-motor growth.
  • 4 tablets/day for pregnant and breastfeeding women.
  • 5 tablets/day for adults in prevention of cardiovascular diseases.

Ingredients: Bulking agents: Microcrystalline cellulose; oil derived from microalga Schyzochitrium sp. rich in Omega 3; anti-caking agents: Magnesium salts of fatty acids, Silicon dioxide.

 

Vegan Friendly: without the use of animal derived substances.

OGM Free:  without the use of substances composed of or derived from genetically modified organisms.

Gluten Free: gluten-free ingredients.

Diabetic Friendly: no added sugar.

Formule Vegan FriendlyProdotti OGM free

Production lot expiring 09/2024.

In stock

Categories: , , , Tags: ,
Print

Description

NUTRA DHA is a dietary supplement based on DHA from oil derived from alga useful to bring an additional fee of this component to the daily diet.

DHA is extracted from the microalga of the genus Schizochytrium sp.

DHA is a semi-essential fatty acid of the Omega3 series, present in fair quantities in fish (salmon, mackerel, sardines, herring, tuna and anchovies) and also in some microalgae that the fish eat.

DHA is known for its properties:

  • Hypolipidemic, useful in reducing blood concentrations of triglycerides and LDL cholesterol.
  • Neuroprotective, effective in protecting the central nervous system from the harmful action of reactive oxygen species.
  • Antioxidants, biologically valuable for various organs and systems, including the reproductive one.
  • Anti-inflammatory, able to extinguish the phlogistic cascade.
  • Immunomodulatory and antiallergic.

Therefore, a correct integration of DHA is recommended  for:

  • Pregnant and breastfeeding women.
  • Subjects suffering from hypercholesterolemia, hypertriglyceridemia or with increased cardiovascular risk.
  • Subjects affected by neurological/neurodegenerative diseases.
  • Subjects suffering from allergic/autoimmune pathologies.

You may also like…

Related products

Go to Top